Accordingly, neutralizing IFN-γ increased tumor burden (albeit not significantly; Figure 4D) and significantly decreased survival of CD73-deficient Eμ-TCL1tg/wt male mice (Figure 4E). The gene discussed is NT5E; the disease is neoplasm.